Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

metreleptin

A recombinant human leptin analog composed of human leptin with the addition of a methionine residue at its amino terminus, that may be used for the treatment of leptin deficiency. Upon administration, metreleptin binds to and activates the human leptin receptor (ObR). This activates leptin/ObR-mediated signaling pathways. Leptin, a hormone predominantly secreted by adipose tissue, plays an important role in maintaining energy homeostasis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	N-methionylleptin
US brand name:	Myalept

metreleptin

Search NCI's Drug Dictionary